COVID-19 TCTMD HUB

Todd Neale

COVID-19: TCTMD’s Daily Dispatch

TCTMD reporter Todd Neale is keeping up on breaking news and peer-reviewed research related to COVID-19 and will update accordingly. If you have something to share, tell us.

LATEST NEWS

Friday, January 14

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Testing patients months after their disease can uncover “tiny, subclinical changes,” German data show.

Friday, January 7

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

But there were positive signs among patients treated early, and ongoing trials will provide more-definitive answers.

Thursday, January 6

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

Data from Israel, albeit based on small numbers, eased concerns about myocarditis after additional Pfizer/BioNTech shots.

Thursday, January 6

Myocardial Injury Tied to Greater Mortality 1 Year After COVID-19 Hospitalization

“Long COVID” symptoms and readmissions also tended to be higher at 6 months among patients with troponin elevations.

Wednesday, December 29

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Rivaroxaban 10 mg/day for 35 days after discharge appears safe and beneficial. Still, editorialists say, larger trials are needed.

Tuesday, December 28

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD a

Even during a pandemic, the AHA says, research on obesity, hypertension, diabetes, and more continues to pay dividends.

Wednesday, December 22

Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk

The updated abstract is more explicit about the limitations of the research, which continues to be embraced by vaccine skeptics.

Friday, December 17

New Insights Into Myocarditis and mRNA COVID-19 Vaccines

Myocarditis, typically mild, was significantly more common with Moderna vaccines than in the unvaxxed, population data show.

Wednesday, December 15

Discharge Safe as Early as a Day After Primary PCI for STEMI

Patients were followed up via a structured virtual program, with no increase in MACE compared with longer stays, a study shows.

Friday, December 10

Large Series Confirms Myocarditis Post-COVID-19 Vax Is Mild in the Young

Fewer than 20% of adolescent patients had impaired LVEF, with function normalizing early on. Long-term data are still lacking.

Thursday, January 13

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

Early numbers hint the already low risk could be even lower after boosters. Pediatric cardiologists—and parents—weigh in.

Monday, December 20

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

From tinkering with care pathways to communicating with patients and staff remotely, some changes seem destined to stay.

Thursday, December 16

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Delayed care, ignored symptoms, stress, isolation, and unhealthy habits: cardiologists need a plan to play catch-up on heart health.

Monday, December 13

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Women, trainees, and cardiologists from lower-income nations enjoyed unique opportunities at virtual meetings. Can it last?

Thursday, December 9

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Lockdowns opened doors for RCTs without in-person contact. Time will tell whether they deliver on diversity and outcomes.

Wednesday, April 21

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Offering opportunities for widespread, iterative learning and increased efficiency, remote learning is here to stay, experts say.

Monday, February 8

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Interim results from an international, multiplatform RCT have been released, but experts urge caution before changing practice.

Wednesday, January 20

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Nurses and techs are quitting permanent jobs for lucrative traveling contracts, leaving hospitals and cath labs scrambling.

Monday, January 11

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Editors grappled with study volume and quality but wanted to publish something—ANYTHING—on the virus’s CV effects.

Monday, December 14

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

The pandemic revealed that research doesn’t have to be the lumbering creature it’s been and can be more agile and efficient.

HEART SOUNDS

Advertisement